IBDEI3IZ ; ; 19-NOV-2015
;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.4,2430,0)
;;=EDUCATION/TRAINING GRP/IND^3^217
;;^UTILITY(U,$J,358.4,2431,0)
;;=SUPPLIES^10^217
;;^UTILITY(U,$J,358.4,2432,0)
;;=ESTABLISHED PT-OUTPT^1^218
;;^UTILITY(U,$J,358.4,2433,0)
;;=INPATIENT CARE^2^218
;;^UTILITY(U,$J,358.4,2434,0)
;;=COMMON PULMONARY DX^1^219
;;^UTILITY(U,$J,358.4,2435,0)
;;=SLEEP DISORDERS^20^219
;;^UTILITY(U,$J,358.4,2436,0)
;;=OBSTRUCTIVE SLEEP APNEA^13^219
;;^UTILITY(U,$J,358.4,2437,0)
;;=OTHER^26^219
;;^UTILITY(U,$J,358.4,2438,0)
;;=CANCER^2^219
;;^UTILITY(U,$J,358.4,2439,0)
;;=CARDIAC^3^219
;;^UTILITY(U,$J,358.4,2440,0)
;;=ENDOCRINE^4^219
;;^UTILITY(U,$J,358.4,2441,0)
;;=ENT^5^219
;;^UTILITY(U,$J,358.4,2442,0)
;;=GASTROINTESTINAL^5^219
;;^UTILITY(U,$J,358.4,2443,0)
;;=GENITOURINARY/RENAL^6^219
;;^UTILITY(U,$J,358.4,2444,0)
;;=HEMATOLOGIC/LYMPHATIC^7^219
;;^UTILITY(U,$J,358.4,2445,0)
;;=HEPATIC/BILIARY^8^219
;;^UTILITY(U,$J,358.4,2446,0)
;;=INFECTIOUS DISEASE^9^219
;;^UTILITY(U,$J,358.4,2447,0)
;;=INTERSTITIAL LUNG DISEASE^10^219
;;^UTILITY(U,$J,358.4,2448,0)
;;=MUSCULOSKELETAL^11^219
;;^UTILITY(U,$J,358.4,2449,0)
;;=SUTURES^23^219
;;^UTILITY(U,$J,358.4,2450,0)
;;=RADIATION^19^219
;;^UTILITY(U,$J,358.4,2451,0)
;;=OCCUPATIONAL^15^219
;;^UTILITY(U,$J,358.4,2452,0)
;;=PAIN^16^219
;;^UTILITY(U,$J,358.4,2453,0)
;;=PLEURAL DISEASE^17^219
;;^UTILITY(U,$J,358.4,2454,0)
;;=PSYCHIATRIC/BEHAVIORAL^18^219
;;^UTILITY(U,$J,358.4,2455,0)
;;=SKIN^22^219
;;^UTILITY(U,$J,358.4,2456,0)
;;=NEUROLOGIC^12^219
;;^UTILITY(U,$J,358.4,2457,0)
;;=OBSTRUCTIVE DISEASE^14^219
;;^UTILITY(U,$J,358.4,2458,0)
;;=VASCULAR^24^219
;;^UTILITY(U,$J,358.4,2459,0)
;;=SYMPTOMS^21^219
;;^UTILITY(U,$J,358.4,2460,0)
;;=ASPIRATION/INJECTION^1^220
;;^UTILITY(U,$J,358.4,2461,0)
;;=INJECTION MEDICATIONS^2^220
;;^UTILITY(U,$J,358.4,2462,0)
;;=ULTRASOUND^3^220
;;^UTILITY(U,$J,358.4,2463,0)
;;=NEW PATIENT^2^221
;;^UTILITY(U,$J,358.4,2464,0)
;;=ESTABLISHED PATIENT^1^221
;;^UTILITY(U,$J,358.4,2465,0)
;;=CONSULTATIONS^3^221
;;^UTILITY(U,$J,358.4,2466,0)
;;=COMMON DIAGNOSES^1^222
;;^UTILITY(U,$J,358.4,2467,0)
;;=CRYSTAL ARTHROPATHIES^2^222
;;^UTILITY(U,$J,358.4,2468,0)
;;=JOINT DISORDERS^5^222
;;^UTILITY(U,$J,358.4,2469,0)
;;=MISCELLANEOUS^6^222
;;^UTILITY(U,$J,358.4,2470,0)
;;=NERVOUS SYSTEM^7^222
;;^UTILITY(U,$J,358.4,2471,0)
;;=OSTEOARTHRITIS^8^222
;;^UTILITY(U,$J,358.4,2472,0)
;;=OSTEOMYELITIS^9^222
;;^UTILITY(U,$J,358.4,2473,0)
;;=OSTEOPOROSIS^10^222
;;^UTILITY(U,$J,358.4,2474,0)
;;=PYOGENIC ARTHRITIS^11^222
;;^UTILITY(U,$J,358.4,2475,0)
;;=SPINE DISORDERS^12^222
;;^UTILITY(U,$J,358.4,2476,0)
;;=TENDINITIS & BURSITIS^13^222
;;^UTILITY(U,$J,358.4,2477,0)
;;=VASCULAR DISORDERS^16^222
;;^UTILITY(U,$J,358.4,2478,0)
;;=VASCULITIS CONDITIONS^15^222
;;^UTILITY(U,$J,358.4,2479,0)
;;=INFECTIONS^3^222
;;^UTILITY(U,$J,358.4,2480,0)
;;=INT DERANGEMENT OF KNEE^4^222
;;^UTILITY(U,$J,358.4,2481,0)
;;=OTHER INFLAMMATORY^10.5^222
;;^UTILITY(U,$J,358.4,2482,0)
;;=VACCINATIONS^13^223
;;^UTILITY(U,$J,358.4,2483,0)
;;=INJECTION^7^223
;;^UTILITY(U,$J,358.4,2484,0)
;;=EDUCATION/TRAINING^3^223
;;^UTILITY(U,$J,358.4,2485,0)
;;=COUNSELING^2^223
;;^UTILITY(U,$J,358.4,2486,0)
;;=EVALUATIONS^4^223
;;^UTILITY(U,$J,358.4,2487,0)
;;=SPINAL INJECTION CODES^9^223
;;^UTILITY(U,$J,358.4,2488,0)
;;=SUPPLIES^10^223
;;^UTILITY(U,$J,358.4,2489,0)
;;=TREATMENT PROCEDURES^11^223
;;^UTILITY(U,$J,358.4,2490,0)
;;=TRIGGER POINT INJECTIONS^12^223
;;^UTILITY(U,$J,358.4,2491,0)
;;=HOME VISIT-ESTABLISHED PT^5^223
;;^UTILITY(U,$J,358.4,2492,0)
;;=HOME VISIT-NEW PT^6^223
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI3IZ 3991 printed Sep 15, 2024@22:13:53 Page 2
IBDEI3IZ ; ; 19-NOV-2015
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
+2 if 'DIFQR(358.4)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,99)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.4,2430,0)
+2 ;;=EDUCATION/TRAINING GRP/IND^3^217
+3 ;;^UTILITY(U,$J,358.4,2431,0)
+4 ;;=SUPPLIES^10^217
+5 ;;^UTILITY(U,$J,358.4,2432,0)
+6 ;;=ESTABLISHED PT-OUTPT^1^218
+7 ;;^UTILITY(U,$J,358.4,2433,0)
+8 ;;=INPATIENT CARE^2^218
+9 ;;^UTILITY(U,$J,358.4,2434,0)
+10 ;;=COMMON PULMONARY DX^1^219
+11 ;;^UTILITY(U,$J,358.4,2435,0)
+12 ;;=SLEEP DISORDERS^20^219
+13 ;;^UTILITY(U,$J,358.4,2436,0)
+14 ;;=OBSTRUCTIVE SLEEP APNEA^13^219
+15 ;;^UTILITY(U,$J,358.4,2437,0)
+16 ;;=OTHER^26^219
+17 ;;^UTILITY(U,$J,358.4,2438,0)
+18 ;;=CANCER^2^219
+19 ;;^UTILITY(U,$J,358.4,2439,0)
+20 ;;=CARDIAC^3^219
+21 ;;^UTILITY(U,$J,358.4,2440,0)
+22 ;;=ENDOCRINE^4^219
+23 ;;^UTILITY(U,$J,358.4,2441,0)
+24 ;;=ENT^5^219
+25 ;;^UTILITY(U,$J,358.4,2442,0)
+26 ;;=GASTROINTESTINAL^5^219
+27 ;;^UTILITY(U,$J,358.4,2443,0)
+28 ;;=GENITOURINARY/RENAL^6^219
+29 ;;^UTILITY(U,$J,358.4,2444,0)
+30 ;;=HEMATOLOGIC/LYMPHATIC^7^219
+31 ;;^UTILITY(U,$J,358.4,2445,0)
+32 ;;=HEPATIC/BILIARY^8^219
+33 ;;^UTILITY(U,$J,358.4,2446,0)
+34 ;;=INFECTIOUS DISEASE^9^219
+35 ;;^UTILITY(U,$J,358.4,2447,0)
+36 ;;=INTERSTITIAL LUNG DISEASE^10^219
+37 ;;^UTILITY(U,$J,358.4,2448,0)
+38 ;;=MUSCULOSKELETAL^11^219
+39 ;;^UTILITY(U,$J,358.4,2449,0)
+40 ;;=SUTURES^23^219
+41 ;;^UTILITY(U,$J,358.4,2450,0)
+42 ;;=RADIATION^19^219
+43 ;;^UTILITY(U,$J,358.4,2451,0)
+44 ;;=OCCUPATIONAL^15^219
+45 ;;^UTILITY(U,$J,358.4,2452,0)
+46 ;;=PAIN^16^219
+47 ;;^UTILITY(U,$J,358.4,2453,0)
+48 ;;=PLEURAL DISEASE^17^219
+49 ;;^UTILITY(U,$J,358.4,2454,0)
+50 ;;=PSYCHIATRIC/BEHAVIORAL^18^219
+51 ;;^UTILITY(U,$J,358.4,2455,0)
+52 ;;=SKIN^22^219
+53 ;;^UTILITY(U,$J,358.4,2456,0)
+54 ;;=NEUROLOGIC^12^219
+55 ;;^UTILITY(U,$J,358.4,2457,0)
+56 ;;=OBSTRUCTIVE DISEASE^14^219
+57 ;;^UTILITY(U,$J,358.4,2458,0)
+58 ;;=VASCULAR^24^219
+59 ;;^UTILITY(U,$J,358.4,2459,0)
+60 ;;=SYMPTOMS^21^219
+61 ;;^UTILITY(U,$J,358.4,2460,0)
+62 ;;=ASPIRATION/INJECTION^1^220
+63 ;;^UTILITY(U,$J,358.4,2461,0)
+64 ;;=INJECTION MEDICATIONS^2^220
+65 ;;^UTILITY(U,$J,358.4,2462,0)
+66 ;;=ULTRASOUND^3^220
+67 ;;^UTILITY(U,$J,358.4,2463,0)
+68 ;;=NEW PATIENT^2^221
+69 ;;^UTILITY(U,$J,358.4,2464,0)
+70 ;;=ESTABLISHED PATIENT^1^221
+71 ;;^UTILITY(U,$J,358.4,2465,0)
+72 ;;=CONSULTATIONS^3^221
+73 ;;^UTILITY(U,$J,358.4,2466,0)
+74 ;;=COMMON DIAGNOSES^1^222
+75 ;;^UTILITY(U,$J,358.4,2467,0)
+76 ;;=CRYSTAL ARTHROPATHIES^2^222
+77 ;;^UTILITY(U,$J,358.4,2468,0)
+78 ;;=JOINT DISORDERS^5^222
+79 ;;^UTILITY(U,$J,358.4,2469,0)
+80 ;;=MISCELLANEOUS^6^222
+81 ;;^UTILITY(U,$J,358.4,2470,0)
+82 ;;=NERVOUS SYSTEM^7^222
+83 ;;^UTILITY(U,$J,358.4,2471,0)
+84 ;;=OSTEOARTHRITIS^8^222
+85 ;;^UTILITY(U,$J,358.4,2472,0)
+86 ;;=OSTEOMYELITIS^9^222
+87 ;;^UTILITY(U,$J,358.4,2473,0)
+88 ;;=OSTEOPOROSIS^10^222
+89 ;;^UTILITY(U,$J,358.4,2474,0)
+90 ;;=PYOGENIC ARTHRITIS^11^222
+91 ;;^UTILITY(U,$J,358.4,2475,0)
+92 ;;=SPINE DISORDERS^12^222
+93 ;;^UTILITY(U,$J,358.4,2476,0)
+94 ;;=TENDINITIS & BURSITIS^13^222
+95 ;;^UTILITY(U,$J,358.4,2477,0)
+96 ;;=VASCULAR DISORDERS^16^222
+97 ;;^UTILITY(U,$J,358.4,2478,0)
+98 ;;=VASCULITIS CONDITIONS^15^222
+99 ;;^UTILITY(U,$J,358.4,2479,0)
+100 ;;=INFECTIONS^3^222
+101 ;;^UTILITY(U,$J,358.4,2480,0)
+102 ;;=INT DERANGEMENT OF KNEE^4^222
+103 ;;^UTILITY(U,$J,358.4,2481,0)
+104 ;;=OTHER INFLAMMATORY^10.5^222
+105 ;;^UTILITY(U,$J,358.4,2482,0)
+106 ;;=VACCINATIONS^13^223
+107 ;;^UTILITY(U,$J,358.4,2483,0)
+108 ;;=INJECTION^7^223
+109 ;;^UTILITY(U,$J,358.4,2484,0)
+110 ;;=EDUCATION/TRAINING^3^223
+111 ;;^UTILITY(U,$J,358.4,2485,0)
+112 ;;=COUNSELING^2^223
+113 ;;^UTILITY(U,$J,358.4,2486,0)
+114 ;;=EVALUATIONS^4^223
+115 ;;^UTILITY(U,$J,358.4,2487,0)
+116 ;;=SPINAL INJECTION CODES^9^223
+117 ;;^UTILITY(U,$J,358.4,2488,0)
+118 ;;=SUPPLIES^10^223
+119 ;;^UTILITY(U,$J,358.4,2489,0)
+120 ;;=TREATMENT PROCEDURES^11^223
+121 ;;^UTILITY(U,$J,358.4,2490,0)
+122 ;;=TRIGGER POINT INJECTIONS^12^223
+123 ;;^UTILITY(U,$J,358.4,2491,0)
+124 ;;=HOME VISIT-ESTABLISHED PT^5^223
+125 ;;^UTILITY(U,$J,358.4,2492,0)
+126 ;;=HOME VISIT-NEW PT^6^223
